Pharmafile Logo
Pharmafocus logo
Advanced Search

Government confirms NHS ‘free’

May 10, 2013
Sales and Marketing Hunt, NHS, avaaz

The government has reaffirmed that NHS treatment “will remain free at the point of delivery and available according to clinical …

News
stan_musial

Egalet appoints Stan Musial as CFO

May 10, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Egalet, musial

Speciality pharma firm Egalet has announced the appointment of Stan Musial as chief financial officer.  Bob Radie, president and chief …

Appointment
danai_brooks

Dyadic International hires chief operating officer

May 10, 2013
Manufacturing and Production, Research and Development, Sales and Marketing dyadic

Biotech firm Dyadic International has appointed Danai Brooks to the role of executive VP and chief operating officer.  Starting in …

Appointment

New Viagra site launched

May 10, 2013
Manufacturing and Production, Medical Communications, Sales and Marketing ED, Pfizer, viagra

Pfizer has launched a new sales website for Viagra, the ‘little blue pill’ which is its most counterfeited medicine, to …

News
Aesica image

Aesica forges alliance with UK university on API synthesis

May 8, 2013
Manufacturing and Production Aesica

UK contract manufacturing organisation (CMO) Aesica has teamed up with the University of Nottingham to develop new ways to form …

News

Manufacturing facility news in brief

May 8, 2013
Manufacturing and Production Expeditors, Novo Nordisk, Penn Pharma, Sagent Pharma, Vertellus

A round-up of new facility developments in the pharma sector, including updates from Novo Nordisk, Sagent, Penn Pharma, Vertellus and …

News
ABPI image

VBP will be ‘unfair’: report

May 8, 2013
Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP

A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …

News
astrazeneca image

AstraZeneca reveals Alderley Park plan

May 8, 2013
Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …

News
mary_s

New UK head at Porter Novelli

May 8, 2013
Medical Communications, Sales and Marketing Porter Novelli, smiddy

PR firm Porter Novelli has announced that Mary Smiddy has been named as its new UK head of health & …

Appointment
J&J, image

Asian regulators take issue with J&J facilities

May 7, 2013
Manufacturing and Production India, J&J, JJ, Korea, inspection

Johnson & Johnson’s manufacturing network is under yet more scrutiny following regulatory actions by authorities in India and South Korea. …

News

Funding boost for GSK open lab

May 7, 2013
Research and Development, Sales and Marketing GSK, Wellcome

GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …

News
Buffet image

Lessons from the business gurus

May 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, buffet, business gurus

Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …

Feature

FleishmanHillard appoints two directors

May 7, 2013
Medical Communications, Sales and Marketing FleishmanHillard

Comms firm FleishmanHillard has added two directors to its Healthcare leadership team. Robert Hanvik and Alison Wright have joined the …

Appointment
Merck image

FDA approves Liptruzet

May 7, 2013
Sales and Marketing FDA, Merck, liptruzet

Merck is celebrating after its once-daily anti-cholesterol pill Liptruzet was approved by US regulators, expanding its indications. The drug – …

News
Teva image

Teva says US facility will close in cost-cutting drive

May 3, 2013
Manufacturing and Production Teva, closure, cuts

Teva has said it will shut down a manufacturing and R&D facility in Pennsylvania by 2017, with the loss of …

News
Sanofi image

Sanofi’s performance dives

May 3, 2013
Sales and Marketing Q1, Sanofi

Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …

News
28569_guenter_100

Sanofi appoints two executive members

May 3, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive

Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …

Appointment

Lundbeck moves ahead in Q1

May 3, 2013
Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1

Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …

News
FDA image

FDA seeks manufacturing data for GSK’s trametinib

May 2, 2013
Manufacturing and Production FDA, GSK, melanoma

GlaxoSmithKline’s melanoma drug candidate trametinib has been delayed in the US by an FDA request for more information on its …

News
Boehringer image

Boehringer and OBT in cancer tie-up

May 2, 2013
Research and Development, Sales and Marketing Boehringer, Cancer, OBT

Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026